Peptivir's Seed Round

Peptivir raised a round of funding on November 19, 2010.

PeptiVir is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of …

Articles about Peptivir's Seed Round: